NRC
National Research Corporation Healthcare - Health Information Services Investor Relations →
National Research Corporation (NRC) closed at $18.54 as of 2026-06-19, trading 29.7% below its 200-week moving average of $26.38. This places NRC in the extreme value zone. The stock is currently moving closer to the line, down from -29.0% last week. The 14-week RSI sits at 64, indicating neutral momentum.
Trading volume is running at 1.7x of its 14-week average, which is in the normal range. The balance between buying and selling volume (0.75 ratio) is neutral — neither side is clearly dominating.
Over the past 634 weeks of data, NRC has crossed below its 200-week moving average 11 times. On average, these episodes lasted 31 weeks. Historically, investors who bought NRC at the start of these episodes saw an average one-year return of +12.4%.
With a market cap of $418 million, NRC is a small-cap stock. The company generates a free cash flow yield of 4.7%. Return on equity stands at 41.9%, indicating strong profitability. The stock trades at 30.9x book value.
The company has been aggressively buying back shares, reducing its share count by 8.1% over the past three years.
Over the past 12.2 years, a hypothetical investment of $100 in NRC would have grown to $154, compared to $487 for the S&P 500. NRC has returned 3.6% annualized vs 13.8% for the index, underperforming the broader market over this period.
Free cash flow has been declining at a -15.9% compound annual rate. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: NRC vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After NRC Crosses Below the Line?
Across 11 historical episodes, buying NRC when it crossed below its 200-week moving average produced an average return of +7.5% after 12 months (median -2.0%), compared to +11.5% for the S&P 500 over the same periods. 45% of those episodes were profitable after one year. After 24 months, the average return was +42.4% vs +24.9% for the index.
Each line shows $100 invested at the moment NRC crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Bean Score Experimental
The Bean Score measures how far a stock's free cash flow yield has deviated from its own quarterly baseline, normalized by the stock's historical behavior. Between earnings dates, FCF is constant — so the score is purely a function of stock price. The levels below show at what prices NRC would reach each dislocation threshold.
Dislocation Price Levels
Prices where NRC's Bean Score would hit each σ threshold. Valid until next earnings report: 2026-07-27.
| Level | σ | Price | Signal |
|---|---|---|---|
| Deep Value | +2σ | $12.91 | Unusually cheap — potential buy zone |
| Value | +1σ | $14.58 | Cheap vs. own history |
| Fair Value | +0σ | $16.75 | Historical mean behavior |
| Expensive | -1σ | $19.68 | Expensive vs. own history |
| Deep Expensive | -2σ | $23.85 | Unusually expensive — potential trim zone |
Quarterly FCF & Yield Trailing twelve-month free cash flow and yield at each quarter end
Signal Accuracy Collecting Data
The Bean Score system is accumulating weekly data to validate signal accuracy. After 13+ weeks of history, this section will display win rates and average returns for each σ threshold crossing — answering the question: "When this score says cheap or expensive, does the price subsequently move in the expected direction?"
Theoretical framework — not backtested or forward-tested. The Bean Score uses trailing twelve-month free cash flow yield as a dislocation identifier. It measures whether the market has pushed a stock's yield unusually far from its own baseline behavior. These levels are reference points for identifying potential swing trade opportunities, not buy/sell signals. FCF values update quarterly with earnings; between reports, all movement is price-driven.
Dislocation Scores Experimental
Each score measures deviation from NRC's own historical baseline — the same idea as the Bean Score, applied to different fundamentals. Positive means cheaper or more dislocated than this stock's norm. Scores marked σ are normalized by the stock's own variability; pp values are simple deltas from its recent baseline.
Theoretical framework — not backtested. These scores describe how unusual today's readings are for this specific company. They are starting points for research, not buy or sell signals. Annual-statement scores (buyback, accruals, FCF vs history) rest on only ~4 yearly data points and are deltas, not sigmas.
Historical Touches
NRC has crossed below its 200-week MA 11 times with an average 1-year return of +12.4% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Apr 2014 | Nov 2014 | 27 | 20.2% | -6.1% | +54.4% |
| Nov 2014 | Oct 2015 | 49 | 20.5% | +11.4% | +70.5% |
| Jan 2016 | Jan 2016 | 2 | 6.8% | +45.7% | +68.7% |
| Feb 2016 | Feb 2016 | 3 | 4.2% | +32.3% | +64.2% |
| Mar 2016 | Mar 2016 | 1 | 1.4% | +35.9% | +59.5% |
| Apr 2016 | Jul 2016 | 12 | 9.5% | +46.0% | +58.4% |
| Dec 2020 | Jan 2021 | 1 | 0.3% | -2.1% | -50.7% |
| Jun 2021 | Jun 2021 | 2 | 4.9% | -16.3% | -52.7% |
| Sep 2021 | Nov 2021 | 6 | 9.2% | -11.6% | -53.6% |
| Nov 2021 | Sep 2023 | 95 | 31.6% | -10.9% | -50.9% |
| Oct 2023 | Ongoing | 141+ | 69.1% | Ongoing | -53.0% |
| Average | 31 | — | +12.4% | — |
Frequently Asked Questions
Is NRC below its 200-week moving average?
Yes. As of 2026-06-19, National Research Corporation (NRC) is trading 29.7% below its 200-week moving average of $26.38. The current price is $18.54.
What is NRC's 200-week moving average price?
National Research Corporation's 200-week moving average is $26.38 as of 2026-06-19. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when NRC drops below its 200-week moving average?
NRC has crossed below its 200-week moving average 11 times in our data. On average, buying at that moment produced a one-year return of +12.4%. These dips have historically been decent entry points. These episodes lasted 31 weeks on average.
Is NRC a good value right now?
Here's what our data says about NRC as of 2026-06-19: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 64. Free cash flow yield is 4.7%. Return on equity is 41.9%. Price-to-book is 30.9x. This is not a buy or sell recommendation — always do your own research.
How does NRC compare to the S&P 500?
Over the past 12.2 years, $100 invested in NRC would have grown to $154, compared to $487 for the S&P 500. That's 3.6% annualized vs 13.8% for the index. NRC has underperformed the broader market over this period.
Does NRC pay a dividend?
Yes. National Research Corporation currently pays a dividend yield of 325.00%.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-06-19